A case report of ultra-rare SMARCD2 deficiency and review of the literature.
文献摘要
Congenital neutropenia (CN) is a heterogeneous group of inborn errors of immunity (IEI) characterized by defective neutrophil development and susceptibility to pyogenic infections. Constitutional neutropenia is a genetically heterogeneous group of disorders, and recent advances in genomic studies have revealed additional genetic causes associated with isolated or syndromic forms of neutropenia, including SMARCD2 deficiency. SMARCD2 is one of the implicated genes that encodes a component of the SWI/SNF chromatin-remodeling complex. Specific granule deficiency type 2 (SGD2) is an ultra-rare, syndromic, autosomal recessive form of CN caused by loss-of-function variants in SMARCD2. Only a small number of cases have been reported across the world to date. The clinical presentation of SGD2 is highly variable, ranging from isolated neutrophil defects to severe multisystem involvement. Here, we describe the twelfth patient diagnosed with a novel homozygous canonical splice site variant (c.1181_1181 + 3del) in the SMARCD2 gene (NM_001098426.2), and provide a comprehensive review of previously published cases to give a broad view of the clinical findings associated with the disease. Detailed characterization of SMARCD2-deficient patients and the underlying functional/molecular abnormalities will help to clarify the role of SMARCD2, particularly in immunity, and may ultimately lead to the development of more effective therapeutic approaches to reduce morbidity and improve quality of life in affected patients.